Skip to main content
Fig. 1 | Cardiovascular Diabetology

Fig. 1

From: Effect of pharmacological treatment on outcomes of heart failure with preserved ejection fraction: an updated systematic review and network meta-analysis of randomized controlled trials

Fig. 1

Flow diagram of the study selection process HF heart failure, MRA mineralocorticoid receptor antagonist, SLGT2 sodium-glucose cotransporter-2, ACEI angiotensin-converting enzyme inhibitor, ARB angiotensin receptor blocker, ARNI angiotensin receptor neprilysin inhibitor, MRA mineralocorticoid receptor antagonist

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840